Duke logo

Effects of Endocrine Therapies in Early Stage ER+ Breast Cancer - Clinical Trial

What is the Purpose of this Study?

We are doing this blood and tissue sample study to learn how endocrine therapy affects immune cells in women. Women with breast cancer will be compare to women without cancer.

What is the Condition Being Studied?

Pre- and Post-menopausal women with early stage ER+ breast cancer starting endocrine therapy

Who Can Participate in the Study?

Adult women with early stage breast cancer who:
- Are estrogen receptor positive
- Have plans to start endocrine therapy
- Are on hormonal birth control if you are a healthy patient

Age Group
Adults

What is Involved?

Women with breast cancer will have a total of 4 blood draws and be asked to answer questionnaires.

Women without breast cancer ("healthy group") will have 4 blood draws and be asked to complete medical questionnaires.

Study Details

Full Title
Evaluation of the Effects of Endocrine Therapies on Immune Cell Repertoire and Function in Early Stage Estrogen Receptor Positive Breast Cancer Patients
Principal Investigator
Medical Oncologist
Protocol Number
IRB:PRO00100408
NCT:NCT03719495
Phase
Phase N/A
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698